Nacuity Pharmaceuticals, Inc.

This study tests whether an experimental tablet called NPI-001 can safely slow or stop vision loss in people with Usher syndrome, a genetic condition that causes blindness and hearing loss. About 49 adults will take either the drug or a placebo for 24 months. The main goal is to …

This study tests a special implant placed in the eye during vitrectomy (a surgery to remove the eye's gel). The implant releases a drug to slow down cataract formation, which often happens after vitrectomy. About 30 adults who need vitrectomy and already have some cataract will t…